Page last updated: 2024-10-27

fluoxetine and Pyrosis

fluoxetine has been researched along with Pyrosis in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
"Endoscopy-negative patients with heartburn who failed once daily PPIs were randomly allocated to receive 6 weeks treatment of fluoxetine, omeprazole, or placebo."9.19Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial. ( Barzin, G; Emami, H; Farrokhi-Khajeh-Pasha, Y; Fotouhi, A; Hajifathalian, K; Mirbagheri, SA; Mirbagheri, SS; Ostovaneh, MR; Saeidi, B, 2014)
"Endoscopy-negative patients with heartburn who failed once daily PPIs were randomly allocated to receive 6 weeks treatment of fluoxetine, omeprazole, or placebo."5.19Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial. ( Barzin, G; Emami, H; Farrokhi-Khajeh-Pasha, Y; Fotouhi, A; Hajifathalian, K; Mirbagheri, SA; Mirbagheri, SS; Ostovaneh, MR; Saeidi, B, 2014)
"Amitriptyline was dosed as follows: 8 mg/day for 6 days, 8 mg twice a day for 6 days, 20 mg/day for 6 days, and 20 mg twice a day for 45 days."2.70Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. ( Alves, LA; Barbosa, JS; Krymchantowski, AV; Silva, MT, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ostovaneh, MR1
Saeidi, B1
Hajifathalian, K1
Farrokhi-Khajeh-Pasha, Y1
Fotouhi, A1
Mirbagheri, SS1
Emami, H1
Barzin, G1
Mirbagheri, SA1
Krymchantowski, AV1
Silva, MT1
Barbosa, JS1
Alves, LA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial[NCT01269788]Phase 2/Phase 3144 participants (Actual)Interventional2010-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for fluoxetine and Pyrosis

ArticleYear
Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial.
    Neurogastroenterology and motility, 2014, Volume: 26, Issue:5

    Topics: Adult; Double-Blind Method; Female; Fluoxetine; Heartburn; Humans; Male; Middle Aged; Omeprazole; Pr

2014
Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study.
    Headache, 2002, Volume: 42, Issue:6

    Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Constipation; Double-Blind Method; Drug Therapy,

2002